Urothelial Carcinoma of the Urethra
📧 Sign up to get email alerts when something new happens for Urothelial Carcinoma of the Urethra.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy [Phase 3]
Phase 3 trial update evaluating the optimal duration of immune checkpoint therapy for locally advanced and metastatic urothelial carcinoma; …
-
CLINICAL_TRIALS trial_result · 2021-12-17Clinical Trial Update: A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer [Phase 2]
Phase 2 study of enfortumab vedotin in locally advanced or metastatic urothelial cancer has been completed and results have been posted. The…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium [Phase 2]
This updates the completion of a Phase 2 trial of sunitinib in patients with progressive metastatic urothelial cancer (transitional cell car…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Arsenic Trioxide in Treating Patients With Urothelial Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide in patients with recurrent urothelial cancers (including bladder, renal pelvis, ureter,…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer [Phase 2]
This document reports the completion and results posting of a Phase II study of AZD4877, an anti-mitotic agent, in advanced bladder cancer a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.